PAVAN S REDDY M.D. NPI 1932161155

NPI Details

Pavan S Reddy, M.D. is a hematology and oncology internal medicine in Wichita, KS with 31 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Pavan S Reddy, M.D. NPI is 1932161155. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

818 N EMPORIA ST
SUITE 403
WICHITA, KS
ZIP 67214-729
Phone: (316) 262-4467
Fax: (316) 262-0706

The NPI 1932161155 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, nivolumab, 1 mg (HCPCS:J9299)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, daratumumab, 10 mg (HCPCS:J9145)
• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, paclitaxel protein-bound particles, 1 mg (HCPCS:J9264)
• Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
• Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram (HCPCS:Q5110)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, docetaxel, 1 mg (HCPCS:J9171)
• Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Injection, bortezomib (velcade), 0.1 mg (HCPCS:J9041)
• Injection, rituximab-abbs, biosimilar, (truxima), 10 mg (HCPCS:Q5115)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
• Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, granisetron, extended-release, 0.1 mg (HCPCS:J1627)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Injection, pegfilgrastim-jmdb, biosimilar, (fulphila), 0.5 mg (HCPCS:Q5108)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Injection, potassium chloride, per 2 meq (HCPCS:J3480)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Cyclophosphamide, 100 mg (HCPCS:J9070)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
• Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Ferritin (blood protein) level (HCPCS:82728)
• Unclassified drugs (HCPCS:J3490)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Magnesium level (HCPCS:83735)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Ct scan of chest with contrast (HCPCS:71260)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Injection of drug or substance into vein (HCPCS:96374)
• Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Infusion, normal saline solution, 250 cc (HCPCS:J7050)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Ct scan of chest without contrast (HCPCS:71250)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml (HCPCS:Q9965)
• Phosphate level (HCPCS:84100)
• Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Vitamin d-3 level (HCPCS:82306)
• Influenza vaccine, quadrivalent, 0.5 ml dosage (HCPCS:90688)
• Total protein level, urine (HCPCS:84156)
• Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
• Manual urinalysis test with examination using microscope, non-automated (HCPCS:81000)
• Calcium level, total (HCPCS:82310)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries (HCPCS:A9503)
• Nuclear medicine study of bone and/or joint whole body (HCPCS:78306)
• Uric acid level, blood (HCPCS:84550)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Folic acid level, serum (HCPCS:82746)
• Blood creatinine level (HCPCS:82565)

The enumeration date for this NPI number is 4/4/2006 and was last updated on 9/29/2011.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.